Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Serum Markers in Preeclamptic Women

This study has been completed.
Information provided by:
Oslo University Hospital Identifier:
First received: May 25, 2011
Last updated: July 3, 2011
Last verified: May 2011
Could possible markers in serum obtained in the first trimester predict the human-pregnancy specific disorder pre-eclampsia?


Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective

Resource links provided by NLM:

Further study details as provided by Oslo University Hospital:

Study Start Date: January 1999
Study Completion Date: May 2004
Primary Completion Date: January 1999 (Final data collection date for primary outcome measure)
  • Control group: 86 healthy women not developing preeclampsia (PE)
  • Case group: 43 women developing PE


Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Norwegian pregnant women

Inclusion Criteria:

  • previous healthy

Exclusion Criteria:

  • Previous inflammatory diseases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01361737

Oslo University Hospital, Rikshospitalet
Oslo, Norway, 0027
Sponsors and Collaborators
Oslo University Hospital
  More Information

Responsible Party: Oslo University Hospital, Rikshospitalet, OsloUH Identifier: NCT01361737     History of Changes
Other Study ID Numbers: NOSERPE11 
Study First Received: May 25, 2011
Last Updated: July 3, 2011
Health Authority: Norway: University of Oslo

Keywords provided by Oslo University Hospital:
serological bio-bank

Additional relevant MeSH terms:
Hypertension, Pregnancy-Induced
Pregnancy Complications processed this record on October 25, 2016